The Digital Source For China's Tech Innovation Since 2000

Immunogenicity, safety, and compliance of high- and standard-strength four-dose hepatitis B vaccination regimens in patients receiving methadone maintenance therapy in China: a randomized, parallel-arm controlled trial

September 15, 2021
Source: firstwordpharma.com firstwordpharma.com
News Snapshot:
You currently are not registered for any FirstWord Pharma services. About FirstWord Pharma | Upgrade Your FirstWord Pharma | Contact FirstWord Pharma | FirstWord ReportsAdvertise with FirstWord Pharma | Industry Partner ShowcaseAll Contents Copyright © 2021 Doctor's Guide Publishing Limited. All Rights Reserved.Terms of Use | Privacy Policy
Go To Original Source →
Tags: | | | | | | |

Other Related News:

© 2022 ChinaTechNews.com. A Service of Asia Media Network.
Twitter